View Older Stories View More Recent Stories

Jan 24, 2018 08:00AM IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase
Jan 9, 2018 08:05AM IsoRay (ISR) Announces Case Report Publication Discussing Focal Radiation Treatment of Brain Metastases with Cesium-131
Jan 9, 2018 08:00AM IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment of Brain Metastases with Cesium-131
Jan 8, 2018 08:00AM IsoRay Announces Manufacturing and Supply Agreement with GT Medical Technologies for GammaTile™ Radiation Therapy System
Jan 8, 2018 08:00AM IsoRay Announces Manufacturing and Supply Agreement with GT Medical Technologies for GammaTile™ Radiation Therapy System
Nov 14, 2017 04:02PM IsoRay Announces First Quarter Fiscal 2018 Financial Results
Nov 9, 2017 08:00AM IsoRay, Inc. Announces the Launch of a Phase II, Multicenter Clinical Trial with Cesium-131 Adjuvant Radiation for Retroperitoneal Sarcoma Delivery System (CARDS Trial) by University of Louisville, Di
Nov 8, 2017 08:00AM IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call
Sep 28, 2017 08:00AM IsoRay Announces Fourth Quarter Fiscal 2017 Revenue of $1.37 Million, 22% Fourth Quarter-over-Fourth Quarter Increase
Sep 26, 2017 08:07AM IsoRay (ISR) Says Study Accepted for Publication in International Journal of Radiation Oncology, Biology, Physics
Sep 26, 2017 08:00AM IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy (PIB): A P
Sep 25, 2017 08:36AM IsoRay (ISR) Announces Poster Presentation at ASTRO Conf.
Sep 25, 2017 08:30AM IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual Am
Aug 31, 2017 08:30AM IsoRay Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017
Aug 4, 2017 08:07AM IsoRay (ISR) Reports Prelim. Q4 Revenue of $1.37M
Aug 4, 2017 08:00AM IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase
Aug 1, 2017 09:05AM New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients
Jul 7, 2017 08:00AM IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer
Jul 6, 2017 08:00AM IsoRay Receives FDA Response to 510(k) Application for GammaTile™
Jun 20, 2017 08:07AM IsoRay (ISR) Reports Published Study on the Impact of Permanent Low-Dose Rate Cesium-131 Brachytherapy on Local Control & Radionecrosis in Patients Treated for Large Brain Metastases
Jun 20, 2017 08:00AM IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection a
May 10, 2017 08:00AM IsoRay Announces Third Quarter Fiscal 2017 Financial Results
May 3, 2017 08:04AM IsoRay (ISR) Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics
May 3, 2017 08:00AM IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with C
Mar 9, 2017 04:22PM IsoRay (ISR) Announces Final Court Approval of Class Action Settlement
Mar 9, 2017 04:05PM IsoRay Announces Final Court Approval of Class Action Settlement
Feb 8, 2017 04:05PM IsoRay Announces Second Quarter Fiscal 2017 Financial Results
Feb 7, 2017 08:30AM MicroCap Review Magazine Winter/Spring 2017 Issue Now Available
Dec 22, 2016 08:30AM IsoRay Medical, Inc. Discusses Cesium-131 and its Applications in New SNNLive Video Interview on StockNewsNow.com
Dec 21, 2016 08:45AM IsoRay (ISR) Reports Launch of Pilot Study Investigating Role of Cesium-131 in Management of Recurrent Head and Neck Cancer
Dec 21, 2016 08:30AM IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Resectable High Risk Recurrent Head and Neck Cancer by Case Comp
Nov 30, 2016 09:00AM IsoRay to Present at 9th Annual LD Micro Investor Conference
Nov 29, 2016 09:04AM IsoRay (ISR) Announces Presentation on Cs-131 Brachytherapy in Recurrent High Grade Glioma
Nov 29, 2016 09:00AM IsoRay Announces "Cesium-131 Brachytherapy for Salvage of Recurrent High Grade Glioma" Poster Presentation at 21st Annual Scientific Meeting of Society for Neuro-Oncology
Nov 8, 2016 06:39PM IsoRay Announces First Quarter Fiscal 2017 Financial Results
Oct 20, 2016 04:15PM IsoRay, Inc. Announces Date for Fiscal 2017 Annual Meeting and Shareholder Record Date
Sep 28, 2016 06:00AM IsoRay, Inc. Announces Launch of Newly Redesigned Patient and Clinician Focused Corporate Website
Sep 27, 2016 06:02AM IsoRay (ISR) Enters Class Action Stipulation of Settlement
Sep 27, 2016 06:00AM IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation
Sep 8, 2016 06:31PM IsoRay Announces Fourth Quarter and Year End Fiscal 2016 Financial Results
Sep 8, 2016 06:31PM IsoRay Announces Fourth Quarter and Year End Fiscal 2016 Financial Results
Aug 16, 2016 09:00AM IsoRay, Inc. to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Jul 6, 2016 08:57AM IsoRay (ISR) Announces Presentation of Encouraging Cesium-131 Data in Gynecologic Cancer Patients
Jul 6, 2016 08:45AM Women's Cancer and Cesium-131 Treatments: Topic of Two Presentations at the 2016 Annual Meeting of the American Brachytherapy Society and World Congress of Brachytherapy
Jun 21, 2016 06:32AM IsoRay (ISR) Announces Presentation of Positive Cesium-131 Brachytherapy Data at SNO Conference
Jun 21, 2016 06:30AM IsoRay® Announces Results of Prospective Trial Presented at Society of Neuro-Oncology Conference
Jun 2, 2016 04:22PM IsoRay's (ISR) Motion to Dismiss Securities Suit Denied by Court
Jun 2, 2016 04:20PM Court Issues Ruling on IsoRay Motion to Dismiss Securities Lawsuit
May 16, 2016 09:00AM IsoRay Provides Update on Motion to Dismiss Securities Lawsuit
May 10, 2016 04:05PM IsoRay Announces Third Quarter Fiscal 2016 Financial Results and Early Conclusions from Ongoing Strategic Review Process
View More Recent Stories View Older Stories